SCHAFER CULLEN CAPITAL MANAGEMENT INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 915 filers reported holding BAXTER INTL INC in Q4 2013. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
SCHAFER CULLEN CAPITAL MANAGEMENT INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2015$4,917,000
-61.8%
149,688
-18.7%
0.06%
-57.9%
Q2 2015$12,873,000
+1.9%
184,080
-0.2%
0.13%
+6.4%
Q1 2015$12,638,000
+99.9%
184,502
+113.9%
0.12%
+56.2%
Q4 2014$6,322,000
-36.6%
86,255
-37.9%
0.08%
-15.8%
Q3 2014$9,968,000
+7.8%
138,895
+8.6%
0.10%
+11.8%
Q2 2014$9,250,000
+4.7%
127,940
+6.5%
0.08%
-1.2%
Q1 2014$8,837,000
+33.7%
120,100
+26.3%
0.09%
+32.3%
Q4 2013$6,611,000
+15.8%
95,060
+9.3%
0.06%
+3.2%
Q3 2013$5,711,00086,9400.06%
Other shareholders
BAXTER INTL INC shareholders Q4 2013
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders